Allina Health reports financial results for Q3: 5 things to know

Minneapolis-based Allina Health’s revenue for the third quarter of this year was $912.2 million, up from $856.3 million for the third quarter of 2013.

Advertisement

Here are five things to know about Allina’s third-quarter financial results.

1. Allina’s expenses for the third quarter of this year were $854.2 million, up from $824.8 million in the third quarter of last year.

2. The system’s expenses related to salaries and benefits grew to $546 million in the third quarter of 2014, up from $520.7 million in the third quarter of 2013.

3. Allina’s expenses for supplies and services increased to $200.8 million in the third quarter of 2014, up from $191.5 million in the third quarter of last year.

4. The system reported operating income of $58 million for the third quarter of this year, up from the $31.5 million it posted for the third quarter of last year.

5. Allina’s net income for the third quarter of this year was $40 million, down from $93.8 million during the same period of last year. 

 

More articles on healthcare finance:

Parkland Memorial Hospital no longer at risk of losing $400M in federal funding
Apollo Medical Holdings’ revenue up 362% in Q2: 5 things to know
For-profit hospital Q3 financial results: 15 things to know

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.